NPS PHARMACEUTICALS, INC. 9,000,000 Shares Common Stock ($0.001 par value) Underwriting AgreementUnderwriting Agreement • April 16th, 2010 • NPS Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledApril 16th, 2010 Company Industry Jurisdiction
Underwriting AgreementUnderwriting Agreement • August 10th, 2009 • Metalico Inc • Secondary smelting & refining of nonferrous metals • New York
Contract Type FiledAugust 10th, 2009 Company Industry JurisdictionMetalico, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to Canaccord Adams Inc. (the “Underwriter”) pursuant to this Underwriting Agreement (this “Agreement”) an aggregate of 6,000,000 shares (the “Firm Shares”) of common stock, $0.001 par value (the “Common Stock”), of the Company. In addition, solely for the purpose of covering over-allotments, the Company proposes to grant to the Underwriter the option to purchase from the Company up to an additional 600,000 shares of Common Stock (the “Additional Shares”). The Firm Shares and the Additional Shares are hereinafter collectively referred to as the “Shares.” The Shares are described in the Prospectus which is referred to below.